The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic aberrations associated with overall survival (OS) in metastatic castration-sensitive prostate cancer (mCSPC) treated with apalutamide (APA) or placebo (PBO) plus androgen deprivation therapy (ADT) in TITAN.
 
Neeraj Agarwal
Consulting or Advisory Role - Astellas Pharma; Astellas Pharma; AstraZeneca; AstraZeneca; AVEO; Bayer; Bristol-Myers Squibb; Calithera Biosciences; Eisai; EMD Serono; Exelixis; Foundation Medicine; Foundation Medicine; Genentech; Gilead Sciences; Janssen Oncology; Lilly; Lilly; Lilly; Medivation/Astellas; MEI Pharma; Merck; Nektar; Novartis; Pfizer; Pfizer; Pharmacyclics; Seagen
Research Funding - Amgen (Inst); Arvinas (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celldex (Inst); crispr therapeutics (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); Immunomedics (Inst); Janssen (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); ORIC Pharmaceuticals (Inst); ORIC Pharmaceuticals (Inst); Pfizer (Inst); Takeda (Inst)
 
Justin Lucas
Employment - Janssen Oncology
Stock and Other Ownership Interests - Johnson & Johnson
 
Clemente Aguilar-Bonavides
Employment - Janssen Oncology
Stock and Other Ownership Interests - Johnson & Johnson
 
Shibu Thomas
Employment - Janssen Oncology
Stock and Other Ownership Interests - Johnson & Johnson
 
Michael Gormley
Employment - Janssen Oncology
Stock and Other Ownership Interests - Johnson & Johnson
 
Simon Chowdhury
Honoraria - Clovis Oncology; Novartis
Consulting or Advisory Role - Astellas Pharma; Bayer; BeiGene; Clovis Oncology; Janssen-Cilag; Novartis; Pfizer
Speakers' Bureau - Janssen-Cilag; Pfizer
Research Funding - Sanofi/Aventis (Inst)
 
Axel S. Merseburger
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Eisai; Ipsen; Janssen-Cilag; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Clovis Oncology; Ipsen; Janssen-Cilag; MSD Oncology; Takeda
Speakers' Bureau - Ipsen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Janssen-Cilag (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen; Janssen-Cilag
 
Anders Bjartell
Stock and Other Ownership Interests - Glactone Pharma; Lidds; WntResearch
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen-Cilag; Merck; Recordati; Sandoz
Speakers' Bureau - Astellas Pharma; Ipsen; Janssen-Cilag
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Ferring (Inst)
Travel, Accommodations, Expenses - Astellas Pharma
 
Hirotsugu Uemura
Honoraria - Bayer; Bristol-Myers Squibb Japan; Janssen; Ono Pharmaceutical; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb Japan; Ono Pharmaceutical; Sanofi
Speakers' Bureau - Bristol-Myers Squibb Japan; Chugai Pharma; Eisai; Janssen; MSD; Pfizer
Research Funding - Astellas Pharma (Inst); Daiichi Sankyo (Inst); Janssen (Inst); Ono Pharmaceutical (Inst); Sanofi (Inst); Takeda (Inst)
 
Mustafa Özgüroğlu
Honoraria - Astellas Pharma; Janssen Oncology (Inst); Novartis
Consulting or Advisory Role - AstraZeneca; MSD Oncology
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Sharon McCarthy
Employment - Janssen Oncology
Stock and Other Ownership Interests - Johnson and Johnson
 
Sabine D. Brookman-May
Employment - Janssen Research & Development
Leadership - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Florence Lefresne
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
Honoraria - Janssen Research & Development
Research Funding - Janssen Research & Development
Travel, Accommodations, Expenses - Janssen Research & Development
(OPTIONAL) Uncompensated Relationships - Janssen Research & Development
 
Suneel Mundle
Employment - Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Kim N. Chi
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Janssen; Merck; Roche
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Constellation Pharmaceuticals; Daiichi Sankyo; ESSA; Janssen; Merck; POINT Biopharma; Roche; Sanofi
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); ESSA (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)
Expert Testimony - AstraZeneca; Novartis